ConductScience.org, home
SK-OV-3
API referenceFor AI assistants

Cell line · CVCL_0532

Papers273

3 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.

1 to 20 of 273

Download this page as JSON
PaperJournalYearHow we knowRetractedSource
Hsa_Circ_0000615-Encoded 250-Amino Acid Polypeptide Suppresses Epithelial Ovarian Cancer Progression via Promoting HMGB1 Nuclear Accumulation.Oncol Res2026Its Methods give the RRID and name the linePubMed
Genetically engineered RNA inducers of proximity for protein regulation.Nat Commun2026Its Methods give the RRID and name the linePubMed
Exosomal circ_0000387 Is Associated With Ovarian Cancer Metastatic Regulation Through IGF2BP3-Related Signalling and Endothelial VWF Responses.J Biochem Mol Toxicol2026Its Methods give the RRID and name the linePubMed
BRCA1 Mutation-Recognizing Tetrahedral Framework Nucleic Acid Nanoplatform Enables Coordinated PARP/WEE1 Inhibition and STING-Associated Antitumor Immunity in Ovarian Cancer.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
Identifying Drug-Induced Metabolic Signatures in Comparative Untargeted NMR Metabolomics Using Difference Spectra.Bioinorg Chem Appl2026Its Methods give the RRID and name the linePubMed
Compartment-specific PPARδ activity controls the outcome of cancer-immune cell competition and immunotherapy efficacy.Nat Immunol2026Its Methods give the RRID and name the linePubMed
ERX-208 Induces Endoplasmic Reticulum Stress and Suppresses DNA Damage Repair to Enhance Chemotherapy Sensitivity.Cancer Res Commun2026Its Methods give the RRID and name the linePubMed
Extracellular vesicle lipidomics liquid biopsy reveals systemic and tumor microenvironment metabolic reprogramming in ovarian cancer.Mol Oncol2026Its Methods give the RRID and name the linePubMed
Preparation and Characterization of Ocimum basilicum Extract-Loaded Niosomes and Evaluation of Their Cytotoxic and Pro-Apoptotic Potential in SKOV3 Ovarian Cancer Cells.Chem Biodivers2026Its Methods give the RRID and name the linePubMed
Paclitaxel induces NM2-dependent cellular contraction through GEF-H1 dissociation from microtubules and RhoA/ROCK activation in cancer cells.Mol Oncol2026Its Methods give the RRID and name the linePubMed
Nuclear localization of the glutaminyl-tRNA synthetase QARS reveals its role in DNA damage response in ovarian cancer.Nat Commun2026Its Methods give the RRID and name the linePubMed
PARP Inhibitors plus Anlotinib as Bridging Therapy for Armored CAR-T Cells in Ovarian Cancer Enhances Infiltration and Antitumor Efficacy.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
DUSP5 contributes to platinum resistance in ovarian cancer: single-cell discovery and functional validation.Front Pharmacol2026Its Methods give the RRID and name the linePubMed
Targeting CD24 Activates Macrophages to Reduce Tumor Burden in Preclinical Models of Solid Tumors.Clin Cancer Res2026Its Methods give the RRID and name the linePubMed
Framework for evaluating in vitro vasculogenic mimicry using structural and metabolic parameters.Cell Rep Methods2026Its Methods give the RRID and name the linePubMed
Inhibition of cyclin-dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation.Mol Oncol2026Its Methods give the RRID and name the linePubMed
Proteomic analysis of malignant ascites and its impact on ovarian cancer spheroids.Clin Proteomics2026Its Methods give the RRID and name the linePubMed
Design optimization of antibody-ligand motifs to enhance CAR-T redirection activity against solid tumors.Cell Rep Med2026Its Methods give the RRID and name the linePubMed
Alpelisib enhances cisplatin mediated cytotoxicity in non-mutated, PIK3CA-dependent high-grade serous ovarian cancer.J Ovarian Res2026Its Methods give the RRID and name the linePubMed
KPNA2 Drives Immunosuppression in Ovarian Cancer via CCL2/CCR2-Dependent MDSC Recruitment.Cancer Sci2026Its Methods give the RRID and name the linePubMed

cell-lines-2026-11-14-0.1.0

Next page

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0532/papers

API referenceFor AI assistants